Amgen is a pioneer in the development and manufacture of therapeutic antibodies
Therapeutic antibodies such as Repatha® are genetically engineered molecules, designed to ensure high specificity and functionality.1 They are biologic medicines, produced using biotechnology – that is, through the genetic modification of living cells or organisms.2
Antibody (immunoglobulin secreted by B cells)1
Amgen is a forerunner in PCSK9i innovation
Amgen has been at the forefront of research and development in PCSK9 inhibition for more than a decade.